PTGX Trade on Dec 4, 2019 12:16 from beno: Tradervue User Stock Trades.

Fundamentals

Shares Outstanding: 27.2m
Cash: 50.2m
Current liabilities: 30.7m
Current ratio: 4.7
NWC (total current assets - total current liabilities): 113m
Monthly Burn rate (net cash used in operating activities / months): 3.03m
Estimated current cash: 44.14m
Accumulated deficit: 200m
Book value per share (Stock holder equity / Shares outstanding): 3.506
Baby Shelf Exemption price per share: 2.76

Catalysts / News / Painting the picture

Announces Preliminary Phase 2 Results for PTG-300 in the Treatment of Transfusion Dependent Beta-Thalassemia
Results warrant continued evaluation of PTG-300 for the potential treatment of beta-thalassemia
4m share diluted since December 2018
Enough cash for 14 months of operation
October 2019 S-3 for $250m
November 22nd ATM prospectus for $75m, Jefferies is underwritter
Won't need cash for awhile but they got a huge shelf if they feel like diluting!!!

Technical Analysis

-Day 1: tanked from $8 to $4.50 on news
-Day 2: squeezed all shorts from day, going from $4.50 back to a morning high of $8.50
-Day 2: sold off to 6.70 then trended up all afternoon, closed near highs

Original Plan / Strategy

First Test long of 7.40 level

Review

Textbook First Test, should have been bigger in this setup but my mental/emotional capital was being occupied by a subpar WLL trade!

Lessons Learned: Don't size up in subpar setups, save capital for the true A+ setups like this!